← Back to Search

GeriKit App for Ischemic Heart Disease

N/A

Recruiting

Led By John A. Dodson, MD, MPH, FACC

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Capable of self-consent

Age ≥ 75

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 6

Awards & highlights

Study Summary

This trial will use an "app" to help better understand & care for older adults in different settings, improving research & care.

Who is the study for?

This trial is for individuals aged 75 or older who are currently hospitalized or were hospitalized within the past month for heart-related procedures like AMI, PCI, or CABG. Participants must be able to consent and perform study tasks in English. Those with severe cognitive issues, non-ambulatory status, incarceration, or inability to complete assessments in English cannot join.Check my eligibility

What is being tested?

The trial is testing the GeriKit mobile application's effectiveness in assessing older adults with ischemic heart disease. The goal is to improve patient care and research by better understanding this population through the app's use.See study design

What are the potential side effects?

Since this trial involves a mobile application rather than a medication, traditional side effects are not applicable. However, participants may experience difficulty using the app due to unfamiliarity with technology or discomfort related to engagement with their health condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am able to understand and agree to the study on my own.

Select...

I am 75 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence of Mortality or Hospital Readmission

Secondary outcome measures

12-Item Short Form Survey (SF-12) Score

Seattle Angina Questionnaire Short-Form (SAQ-7)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Geriatric Assessments using GeriKit AppExperimental Treatment1 Intervention

Participants will receive comprehensive geriatric assessment via GeriKit app at baseline. All participants will complete a follow-up assessment via phone at 6 months. 20 of the 150 enrolled participants will continue onto a qualitative questionnaire after the completion of the 6-month follow up call.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH

2,701 Previous Clinical Trials

7,506,700 Total Patients Enrolled

10 Trials studying Coronary Artery Disease

11,741 Patients Enrolled for Coronary Artery Disease

NYU Langone HealthLead Sponsor

1,369 Previous Clinical Trials

840,448 Total Patients Enrolled

21 Trials studying Coronary Artery Disease

15,028 Patients Enrolled for Coronary Artery Disease

John A. Dodson, MD, MPH, FACCPrincipal InvestigatorNYU Langone Health

Media Library

Geriatric Assessments using GeriKit App Clinical Trial Eligibility Overview. Trial Name: NCT05788666 — N/A

Coronary Artery Disease Research Study Groups: Geriatric Assessments using GeriKit App

Coronary Artery Disease Clinical Trial 2023: Geriatric Assessments using GeriKit App Highlights & Side Effects. Trial Name: NCT05788666 — N/A

Geriatric Assessments using GeriKit App 2023 Treatment Timeline for Medical Study. Trial Name: NCT05788666 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the target demographic of this experiment limited to those over fifty years old?

"This research endeavour seeks to enroll individuals aged between 75 and 100 years."

Answered by AI

Who does this medical experiment target for involvement?

"The necessary criteria for enrollment in this trail is coronary artery disease and an age between 75 and 100. This experiment looks to recruit around 150 participants."

Answered by AI

Are there any vacancies in this trial that a patient could take advantage of?

"As of this moment, the medical trial in question is not actively recruiting. It was initially posted on August 1st 2023 and edited for the last time mid-March of the same year. Nevertheless, there are currently 1092 other clinical trials that need participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease

2024. "Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05788666.

All > Anterior Ischemic Optic Neuropathy > Heart Disease